vimarsana.com

Latest Breaking News On - Mechanism of action - Page 2 : vimarsana.com

Recent Agents for Treatment of IgAN

Chee Kay Cheung, MBCHB, MRCP, PhD, reviews newly approved agents for the treatment of IgAN, focusing on SGLT2 inhibitors, budesonide, and sparsentan.

Chee kay cheungNewer agentsSglt2 inhibitorsMechanism of action

New Treatment Options in MDD

Roger S. McIntyre, MD, FRCPC; and Carmen Kosicek, MSN, PMHNP-BC; review the mechanism of action of newer therapies in MDD treatment.

Rogers mcintyreCarmen kosicekGabaa receptor modulatorsMajor depressive disorderRapid acting therapies in mddMechanism of action

Antimicrobial Resistance Market to Reach $9 5 Billion, Globally, by 2032 at 7 6% CAGR: Allied Market Research

/PRNewswire/ Allied Market Research published a report, titled, "Antimicrobial Resistance Market By Drug Class (Combination Therapies, Tetracyclines,.

Hong kongUnited statesUnited kingdomDavid correaPawan kumarSemiconductor electronicsLibrary premiumCumberland pharmaceuticalsAcurx pharmaceuticals incBasilea pharmaceutica ltdMerck and co incMarket researchCommunity acquired pneumoniaEnergy powerLife sciencesPrnewswire allied market research

Myelofibrosis: Potential Impact of Pacritinib on Anemia

Experts continue their conversation on pacritinib in myelofibrosis by reviewing its potential impact on anemia and ACVR1.

Potential impactMf cancerPrimary myelofibrosisMechanism of actionAcvr1 inhibitionIrak inhibitorsIrak inhibition

AD Clinical Approach: Switching Therapies

Christopher G. Bunick, MD, PhD, shares their clinical approach for switching therapies for atopic dermatitis (AD) treatment.

Christopherg bunickAtopic dermatitisMechanism of action

vimarsana © 2020. All Rights Reserved.